Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voran Group Ventures is a private Canadian company focused on health and hygiene, antimicrobial disinfection, decontamination, and commercialization services. The company markets Bacoban cleaner and disinfectant products and has received Health Canada market authorization for Bacoban (106) Cleaner & Disinfectant for use in hospitals, healthcare facilities, food premises, and institutional or industrial settings. Voran has also promoted SoRite DECON, a decontamination product intended for frontline response to hazardous substances including fentanyl. In addition to selling finished products, the company positions itself as a commercialization partner for innovative antimicrobial and decontaminant technologies. The business appears to operate at the intersection of healthcare products, wellness, and specialty chemical solutions rather than as a traditional therapeutics biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voran Group Ventures.